TY  - CHAP
M1  - Book, Section
TI  - Nosocomial Pneumonia, Including Ventilator-associated Pneumonia
A1  - Roth, Andrew T.
A1  - Kollef, Marin H.
A2  - Grippi, Michael A.
A2  - Antin-Ozerkis, Danielle E.
A2  - Dela Cruz, Charles S.
A2  - Kotloff, Robert M.
A2  - Kotton, Camille Nelson
A2  - Pack, Allan I.
PY  - 2023
T2  - Fishman’s Pulmonary Diseases and Disorders, 6e
AB  - Hospital-acquired  pneumonia  (HAP)  and  ventilator-associated  pneumonia  (VAP)  are  the  most  frequent  causes  of  healthcare-associated  infections  (HAIs)  and  represent  significant  clinical  and  economic  burdens  on  healthcare  systems.  Definitions  for  each  of  these  conditions  are  provided  in  Table  129-1.  HAP  and  VAP  are  frequently  associated  with  multidrug-resistant  (MDR)  microorganisms,  leading  to  further  morbidity  and  mortality  in  hospitalized  patients.  VAP  is  considered  a  device-associated  HAI  and  is,  therefore,  reported  to  the  National  Healthcare  Safety  Network  (NHSN),  the  surveillance  branch  of  the  Centers  for  Disease  Control  and  Prevention  (CDC).  According  to  the  latest  published  data  from  the  NHSN,  10,037  cases  of  VAP  were  reported  from  2015  to  2017.1  This  chapter  focuses  on  the  epidemiology  of  infection,  the  microorganisms  responsible  for  infection,  the  complexities  surrounding  the  diagnosis,  and  the  preventive  and  therapeutic  management  strategies  used  to  combat  nosocomial  pneumonia.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/23
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1195015191
ER  -